CRISPR/Cas12a is extensively utilized for pathogen detection
owing
to its high specificity and efficiency. However, traditional single-CRISPR/Cas12a
encounters challenges due to its limited sensitivity, requiring pre-amplification
of nucleic acids. This increases the complexity of the procedure and
the potential for cross-contamination and false positives. Herein,
a modular dual-CRISPR approach was developed coupled with hybridization
chain reaction (HCR) for the universal and sensitive detection of
pathogen nucleic acids without the need for pre-amplification. The
system comprises two core modules: the first CRISPR/Cas12a recognition
module specifically identifies pathogen targets and releases the activating
agent, while the second CRISPR/Cas12a signal module is activated by
this agent to initiate the HCR reaction for generating a strong fluorescent
signal through DNA nanostructure self-assembly. Through rational design,
we demonstrate the ability of this dual-CRISPR system to achieve attomolar
(aM) level sensitivity for pathogen nucleic acid detection without
pre-amplification,
showing over six-order-of-magnitude higher sensitivity than a traditional
single-CRISPR/Cas12a system. Additionally, the flexibility and versatility
of the modular dual-CRISPR system have been confirmed for diverse
pathogen targets, such as African swine fever virus (ASFV), severe
fever with thrombocytopenia syndrome virus (SFTSV), and human papillomavirus
type 16 (HPV-16) DNA. The system’s practicality was demonstrated
by examining ASFV quality control samples in complex environments.
The exploration of the pre-amplification-free dual-CRISPR system offers
a new perspective on enhancing pathogen nucleic acid detection systems.